Our Firm
Strategies
Values
Portfolio
News
Investor Portal

Contact

100 North Main Street
Suite 301
Alpharetta, GA 30009

One Penn Plaza
Suite 1620
New York, NY 10119

contact@avego.com
646-844-0030

Our Firm
Strategies
Values
Portfolio
News
Investor Portal

Memento Medicines

Posted on July 20, 2026 by James Flexner -

Clinical-stage biotechnology company developing biologic therapies for retinal diseases.

Search for:

Recent Posts

Memento Medicines Launches with $93 Million Series A Financing
Alveus Therapeutics Launches with $160 Million Series A Financing
EpiBiologics Closes $107M Series B
myTomorrows Raises $29 Million
MapLight Therapeutics Announces $372.5 Million Series D Financing
CellCentric Secures $120 Million Investment

Recent Comments

Links

Our Firm
Avego Healthcare Capital
Avego BioScience Capital
Velan Capital

Contact

100 North Main Street, Suite 301
Alpharetta, GA 30009

One Penn Plaza, Suite 1620
New York, NY 10119

contact@avego.com
646-844-0030

Legal

Terms of Use

© 2026 Avego.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptTerms of Use